Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kunbi Xiao Prescription for female rheumatoid arthritis
ChiCTR2200057177Phase 2Not yet recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Feb 2022
- Countries
- 1
01
Overview
Phase 2, randomised trial of kunbixiao decoction in rheumatoid arthritis (RA) (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Mean disease activity score for 28 joints. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
kunbixiao decoction
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR2200057177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057177.